Clinical trial
DYNAMX Bioadaptor ImplanTation for the trEatment of Complex Coronary Lesions (DYNAMITE Study)
NCT05464147 is registered in ClinicalTrials.gov with Elixir Medical Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- DYNAMX Bioadaptor ImplanTation for the trEatment of Complex Coronary Lesions (DYNAMITE Study)
- Lead sponsor
- Elixir Medical Corporation
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 19, 2021
- Completion date
- August 1, 2025
- Enrollment
- 55 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bifurcation of coronary artery, chronic total occlusion of coronary artery, coronary artery disease, long lesions coronary artery disease, multi vessel coronary artery disease